For technology companies, especially monopoly technology companies, fines are nothing more than passing costs on to consumers.

When making internal budgets, fines will be estimated in advance.

The most fearful thing is that the market is blocked and you are not allowed to enter the market at all.

They want to cultivate their own businesses.

This is unacceptable to monopolistic companies.

Li Miaomiao: "The commercial department of the Europa Union has approached us and hopes that Kechuang Biotech will increase its investment in the Europa Union."

"Because our current investment in the Europa continent is mainly in England, and our investment in other parts of Europe is very small."

Li Shuyao: "This is your internal strategic plan. Why should the Europa Union interfere?"

"The languages ​​of the Europa Union are not unified. But this market is very important for console games."

"It's very contradictory, but if the Europa Union bans brain-computer-connected VR from entering its market, it's not just you who should be worried, Goose Factory will be even more worried."

“I heard from my colleagues that Goose Factory internally regards VR as a new strategic direction.”

"I would like to ask if Kechuang will be listed in the future? CICC leaders are already asking about it. If it is listed, CICC can help you with the underwriting."

CICC’s senior management knows exactly what the relationship behind each person is.

Li Shuyao's greatest value is not her academic qualifications or her appearance, but that she is Li Miaomiao's sister and can get first-hand information about science and technology.

Therefore, being able to enter CICC is a blessing and a tragedy for Li Shuyao.

However, in Li Shuyao's view, this is just a small matter and will not affect her mentality.

To be honest, if you can't resist this kind of pressure, there is no need to be involved in the financial circle.

Another benefit of being backed by Science and Technology Biotechnology is that she only needs to do her job well and get some information when the time is right.

Li Miaomiao thought for a while and said: "If we want to design VR chips, we may need financing."

"But I talked to the executives of Goose Factory and Rice about this matter, and they both said they were not in a hurry to go public."

"If Kechuang does not have enough liquidity in the future, we will inject capital in proportion."

"So we have no internal consensus on whether it will be listed or not."

Kechuang's future brain-computer connection VR chips still need to be imported. The only self-produced ones are the brain-computer connection chips and AI computing chips.

Li Shuyao: "If we want to develop self-developed chips, the investment will be huge, and the output may not be achieved."

"It took many years to raise HiSilicon before it finally came to fruition. The earliest HiSilicon chips were used in OEM machines."

"It's not an easy decision to make, but eating from the lower reaches of the industrial chain to the upper reaches is also a breakthrough route."

"Kechuang Biotechnology's annual profits can afford to support a chip design team, and you can even cooperate with SMIC."

"SMIC's 7nm chip is said to be tape-out next year."

Li Miaomiao: "It is said, I just heard that the technology of Huaweigan's biological storage server was obtained from Merlin."

Li Shuyao was shocked: "Where did you get the news? I've never heard of it, and wasn't the biostorage technology developed by Deep Blue Storage?"

"We went to Deep Blue Storage to investigate, and all the R&D personnel there were directly transferred from the Chinese Academy of Sciences."

"Shuguang, Inspur, and Ziguang all want to build their own biological storage servers. It is said that they are waiting for Deep Blue Storage to release production capacity."

"But if the biological storage technology is provided by Merlin, then has our country reached some kind of cooperative relationship with Merlin?"

"No wonder the domestic semiconductor stocks have been falling continuously during this period. I want to clear out my semiconductor ETF!" Li Shuyao suddenly realized.

CICC employees cannot buy and sell stocks in Big A, but they can buy ETFs.

Li Miaomiao sighed: "This is just a rumor in the market and has not been confirmed at the official level."

"But a very important point is that if Merlin provides biological storage technology, then he most likely has biological computer technology in his hands."

"When the biocomputer is launched, it will be a dimensionality-reducing blow to semiconductors."

"To invest in chip design now, the unknown risk is too great."

Li Shuyao analyzed: "Even if there is biocomputer technology, the replacement of silicon-based computer technology will still require a process."

"It will certainly not be that one day all of them will be suddenly replaced by biological computers. During the gradual replacement process, silicon-based computers and biological computers will reach a certain balance."

"I think it is possible to invest. Industrial integration is a major trend. It is better to do it early than to do it late."

“Make risk control calculations before investing.”

Li Miaomiao sighed: "There is a lot of pressure. I feel like there is nothing else but work every day."

"There is no incremental business anymore at work. If you want to do incremental business, you need to consider many factors. I am very afraid that the incremental business will fail."

"I'm afraid that if I make a mistake on my errand, I'll injure my muscles and bones."

Li Shuyao shouted: "You are a bit like Versailles. The current size of Kechuang Biotechnology and the technical barriers you have built can make you make strategic mistakes more than twice."

"You are a technology monopoly, unlike Goose Factory, which relies on the moat built by the number of users."

"The company you benchmark against in history should be IBM. Back then, IBM missed the personal PC wave and the mobile Internet. Isn't it still living a good life now?"

IBM, the blue giant, has a history of more than a hundred years and is still ranked in the top 50 of the world's top 500 companies in 2024.

"You should learn from IBM and encourage internal patent innovation and application. More patents will always come in handy."

Li Miaomiao: "If Kechuang Biotech can live this long, I will be satisfied."

“Investing in internal research and development requires money and people who can afford it.”

“Currently, Kechuang Biotech’s main sources of profit are the patent licensing of brain-computer connection to mobile phones and the patent licensing of endorphins.”

"It still depends on how effective the brain-computer connection to VR will be this time."

...

Bilibili has had a hard time in the past few years. Its stock price has halved from its high point, and it even has to return to the Hong Kong stock market from Nasdaq to relist.

Secondly, the launch of pre-roll ads was boycotted by users, and the number of major members paying has been declining year after year.

Later, the pre-title ads were removed, but the reputation among users was not restored.

It's okay to have sex for free, but if you want me to top up the money, forget it.

The decline in the income of the up owner has led to a decline in video quality.

The strategic transformation cannot find a direction, and it is not an exaggeration to describe it as a failure.

As a first-line content and entertainment platform in China, Bilibili has naturally obtained a brain-computer connection VR sample from Kechuang Future.

After using it, they have new ideas.

“Brain-computer connected VR can definitely become an important part of our future.

We can do VR videos and VR live broadcasts."
Chapter completed!